Approval · Notice of Compliance 25857 · 2021
MAXALT: Notice of Compliance 25857
Issued May 12, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25857
- Date
- May 12, 2021
- Company
- Organon Canada Inc.Kirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in product ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MAXALT | 02240521 | Marketed |
| MAXALT RPD | 02240518 | Marketed |
| MAXALT RPD | 02240519 | Marketed |
Medicinal ingredients
- RIZATRIPTAN BENZOATE 10 MG per TAB
- RIZATRIPTAN BENZOATE 5 MG per TAB